Detalhe da pesquisa
1.
A Herpes Simplex Virus 1 DNA Polymerase Multidrug Resistance Mutation Identified in a Patient With Immunodeficiency and Confirmed by Gene Editing.
J Infect Dis
; 228(11): 1505-1515, 2023 11 28.
Artigo
Inglês
| MEDLINE | ID: mdl-37224525
2.
New Perspectives in Treating Acute Myeloid Leukemia: Driving towards a Patient-Tailored Strategy.
Int J Mol Sci
; 23(7)2022 Mar 31.
Artigo
Inglês
| MEDLINE | ID: mdl-35409248
3.
Hepatosplenic T-cell lymphoma: treatment challenges.
Curr Opin Oncol
; 33(5): 406-411, 2021 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34409955
4.
Thyroid nocardiosis: Case report and review of the literature.
Transpl Infect Dis
; 23(4): e13594, 2021 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-33650134
5.
Risk-adapted transplant strategies for high-risk Hodgkin lymphoma: are we there?
Curr Opin Oncol
; 28(5): 390-7, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27467971
6.
Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients.
Haematologica
; 105(1): e13-e16, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31097634
7.
Reducing mortality in newly diagnosed standard-risk acute promyelocytic leukemia in elderly patients treated with arsenic trioxide requires major reduction of chemotherapy: a report by the French Belgian Swiss APL group (APL 2006 trial).
Haematologica
; 103(11): e519-e521, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-29794147
8.
High-dose therapy and autologous stem cell transplantation in first relapse for diffuse large B cell lymphoma in the rituximab era: an analysis based on data from the European Blood and Marrow Transplantation Registry.
Biol Blood Marrow Transplant
; 18(5): 788-93, 2012 May.
Artigo
Inglês
| MEDLINE | ID: mdl-22005647
9.
Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: combined phase I/II results of the EORTC/GIMEMA AML-14A trial.
Haematologica
; 102(2): e47-e51, 2017 02.
Artigo
Inglês
| MEDLINE | ID: mdl-27789677
10.
Critically ill cancer patient's resuscitation: a Belgian/French societies' consensus conference.
Intensive Care Med
; 47(10): 1063-1077, 2021 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-34545440
11.
Photo quiz. Dyspnea and fever in an allogeneic stem cell recipient.
Clin Infect Dis
; 60(1): 100, 157-8, 2015 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25504499
12.
Limited efficacy and tolerance of imatinib mesylate in steroid-refractory sclerodermatous chronic GVHD.
Blood
; 120(25): 5089-90, 2012 Dec 13.
Artigo
Inglês
| MEDLINE | ID: mdl-23243159
13.
Membrane-bound interleukin (IL)-15 on renal tumor cells rescues natural killer cells from IL-2 starvation-induced apoptosis.
Cancer Res
; 67(12): 5594-9, 2007 Jun 15.
Artigo
Inglês
| MEDLINE | ID: mdl-17575122
14.
Retrospective chart review of hospitalizations and costs associated with the treatment of adults with Philadelphia-negative B-cell relapsed or refractory acute lymphoblastic leukemia in Belgium.
Acta Clin Belg
; 72(6): 429-433, 2017 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-28406385
15.
Dissociated responses to newer antimyeloma drugs identify a subset of refractory patients with an extremely poor prognosis.
Eur J Cancer
; 49(2): 411-5, 2013 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-22980726
16.
Chronic myeloid leukemia and allogeneic natural killer cells: a surprising dialogue.
Expert Rev Clin Immunol
; 2(4): 627-37, 2006 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-20477618
17.
The decreased susceptibility of Bcr/Abl targets to NK cell-mediated lysis in response to imatinib mesylate involves modulation of NKG2D ligands, GM1 expression, and synapse formation.
J Immunol
; 176(2): 864-72, 2006 Jan 15.
Artigo
Inglês
| MEDLINE | ID: mdl-16393970
18.
The t(1;9)(p34;q34) fusing ABL1 with SFPQ, a pre-mRNA processing gene, is recurrent in acute lymphoblastic leukemias.
Leuk Res
; 35(7): e114-7, 2011 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-21388681